Article Sidebar

PDF (Tiếng Việt)
Published: 2024-07-31
Abstract Views: 49
Views PDF (Tiếng Việt): 36
DOI: https://doi.org/10.52852/tcncyh.v179i6.2468
Issue
Vol. 179 No. 6 (2024)
Section
Các bài báo
How to Cite
Yến, T. T. N., Yến, N. T. H., Hà, N. M., & Phượng, Đào T. T. (2024). 5. The outcomes of oocyte vitrification in patients undergoing IVF at Hanoi Medical University Hospital. Journal of Medical Research, 179(6), 37-46. https://doi.org/10.52852/tcncyh.v179i6.2468

5. The outcomes of oocyte vitrification in patients undergoing IVF at Hanoi Medical University Hospital

Trinh Thi Ngoc Yen, Ngo Thi Hai Yen, Nguyen Manh Ha, Dao Thi Thuy Phuong

Main Article Content

Abstract

A retrospective cross-sectional study was conducted at the IVF center of Hanoi Medical University Hospital from June 2021 to January 2024 in patients who had vitrified – thawed oocyte to evaluate the survival rate of oocyte vitrification, fertilization rate, embryo formation rate and the number of day 2 embryos. A total of 419 vitrified oocytes from 100 patients were thawed. The survival rate, fertilization rate and embryo formation rate of frozen oocytes were 91.99%, 81% and 72.7%, respectively. The average number of day 2 embryos was 2.95 ± 2.42. There were no statistically difference in fertilization rate, embryo formation rate and number of day 2 embryos between frozen and fresh oocyte in patients having oocyte accumulation. The results of this study initially showed that oocyte vitrification was effective in in-vitro fertilization.

Article Details

Keywords

Oocyte cryopreservation, vitrification, survival rate, fertilization rate, embryo formation rate

References

1. Chang CC, Shapiro DB, Nagy ZP. The effects of vitrification on oocyte quality. Biology of Reproduction. 2022; 106(2): 316-327. doi:10.1093/biolre/ioab239.
2. Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013; 99(1): 37-43. doi:10.1016/j.fertnstert.2012.09.028.
3. Cobo A, García-Velasco JA, Remohí J, Pellicer A. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertility and Sterility. 2021; 115(5): 1091-1101. doi:10.1016/j.fertnstert.2021.02.006.
4. Ethics Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org. Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion. Fertil Steril. 2018; 110(3): 380-386. doi:10.1016/j.fertnstert.2018.05.034.
5. Li S, Nong Y, Wang F, et al. Clinical efficacy analysis of oocyte cryopreservation: A propensity score matched study. Journal of Obstetrics and Gynaecology Research. 2022; 48(12): 3152-3159. doi:10.1111/jog.15412.
6. Kuwayama M, Vajta G, Kato O, Leibo SP. Highly efficient vitrification method for cryopreservation of human oocytes. Reproductive BioMedicine Online. 2005; 11(3): 300-308. doi:10.1016/S1472-6483(10)60837-1.
7. Đồng thuận phôi by HOSREM HOSREM - Issuu. Accessed October 28, 2022. https://issuu.com/huynhhoa/docs/layout_dtp_7-12_2_.
8. Cobo A, Garrido N, Crespo J, José R, Pellicer A. Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online. 2012; 24(4): 424-432. doi:10.1016/j.rbmo.2011.12.012.
9. Lee KS, Lin MH, Hwu YM, Yang JH, Lee RKK. The live birth rate of vitrified oocyte accumulation for managing diminished ovarian reserve: a retrospective cohort study. Journal of Ovarian Research. 2023; 16(1): 49. doi:10.1186/s13048-023-01128-y.
10. Cobo A, Meseguer M, Zulategui J, Crespo J, Pellicer A, Remohi J. Advanced maternal age is negatively affecting survival and clinical outcome of vitrified oocytes. Fertility and Sterility. 2008; 90:S279. doi:10.1016/j.fertnstert.2008.07.1081.
11. Buderatska N, Gontar J, Ilyin I, Lavrinenko S, Petrushko M, Yurchuk T. Does human oocyte cryopreservation affect equally on embryo chromosome aneuploidy? Cryobiology. 2020; 93: 33-36. doi:10.1016/j.cryobiol.2020.03.002.
12. Melado L, Arnanz A, Bayram A, et al. Anti-Müllerian hormone is an independent marker for oocyte survival after vitrification. Reprod Biomed Online. 2020; 41(1): 119-127. doi:10.1016/j.rbmo.2020.03.014.
13. Khả LTH, Cầm TT, Toàn PD. Kết quả đông lạnh noãn ở bệnh nhân điều trị thụ tinh trong ống nghiệm. Tạp chí Phụ Sản. 2020;18(1):45-48. doi:10.46755/vjog.2020.1.778.
14. Walker Z, Lanes A, Ginsburg E. Oocyte cryopreservation review: outcomes of medical oocyte cryopreservation and planned oocyte cryopreservation. Reprod Biol Endocrinol. 2022; 20:10. doi:10.1186/s12958-021-00884-0.
15. Cornet-Bartolomé D, Rodriguez A, García D, Barragán M, Vassena R. Efficiency and efficacy of vitrification in 35 654 sibling oocytes from donation cycles. Hum Reprod. 2020; 35(10): 2262-2271. doi:10.1093/humrep/deaa178.